[1]
“Carvacrol Conjugated Zinc Oxide Nanoparticles as Prospective Agents against Clinically Isolated Carbapenem Resistant Acinetobacter Species”, mfm, vol. 33, no. 9, Apr. 2024, Accessed: Dec. 26, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/1042